Ascentage Pharma Group International: which funds bought and sold
Institutions that bought and sold Ascentage Pharma Group International shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 4 institutions that filed 13F reports for both quarters added to or opened positions in Ascentage Pharma Group International, and 4 cut or closed them. Together they sold a net 15K shares, −50.4% on what they held at the start of the quarter. Active managers and hedge funds on our list were net sellers of 2,215 shares (−13.8%); index fund managers were net buyers of 6 shares. 3 opened a new position and 2 sold out entirely.
Bought, Q2 2026 4 institutions, 3 of them new holders Sold, Q2 2026 4 institutions, 2 of them sold out
Net change, all compared −15K shares (−50.4%)
Net change, active managers −2,215 shares (−13.8%), 0 bought, 1 sold
Buyers versus sellers
4 bought 1 4 sold
Active managers and hedge funds 0 bought · 1 sold · −2,215
Index fund managers 1 bought · 0 sold · +6
Other institutions 3 bought · 3 sold · −13K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Morgan Stanley | +421 +84.5% | 919 | $16,138 |
| Wells Fargo & Company | +200 New position | 200 | $3,512 |
| Blackrock, Inc. Index funds | +6 New position | 6 | $105 |
| Caitong International Asset Management Co., Ltd | +1 New position | 1 | $18 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| None of the active managers on our list. | |||
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Xy Capital Ltd | −13K Sold out | 0 | — |
| Point72 Asset Management, L.P. Hedge fund | −2,215 −13.8% | 14K | $243,048 |
| Tower Research Capital LLC (TRC) | −518 Sold out | 0 | — |
| UBS Group AG | −109 −87.9% | 15 | $263 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Point72 Asset Management, L.P. Hedge fund | −2,215 −13.8% | 14K | $243,048 |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Wells Fargo & Company | 200 | $3,512 |
| Blackrock, Inc.Index funds | 6 | $105 |
| Caitong International Asset Management Co., Ltd | 1 | $18 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Xy Capital Ltd | 13K | $310,644 |
| Tower Research Capital LLC (TRC) | 518 | $12,365 |
Who holds the shares
- Institutions reporting
- 7
- Ten largest holders
- 100.0% of 13F-reported shares
- Index fund managers
- 0.0% of 13F-reported shares
- Active managers and hedge funds
- 92.2% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 0 | 1 | 0 | 0 | −2,215 | −13.8% |
| Index fund managers | 1 | 0 | 1 | 0 | +6 | — |
| Other institutions | 3 | 3 | 2 | 2 | −13K | −91.8% |
← Back to Ascentage Pharma Group International · Insiders · Politicians